Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
WNT SIGNALING PATHWAY |
71 |
351 |
3.368e-97 |
1.567e-93 |
2 |
CANONICAL WNT SIGNALING PATHWAY |
34 |
95 |
1.156e-53 |
2.689e-50 |
3 |
REGULATION OF WNT SIGNALING PATHWAY |
45 |
310 |
6.758e-52 |
1.048e-48 |
4 |
NON CANONICAL WNT SIGNALING PATHWAY |
36 |
140 |
7.969e-51 |
9.27e-48 |
5 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
32 |
197 |
4.625e-38 |
4.304e-35 |
6 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
33 |
236 |
5.225e-37 |
4.052e-34 |
7 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
63 |
1929 |
2.423e-34 |
1.611e-31 |
8 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
48 |
1021 |
4.922e-32 |
2.863e-29 |
9 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
55 |
1492 |
7.468e-32 |
3.861e-29 |
10 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
57 |
1672 |
2.074e-31 |
9.651e-29 |
11 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
26 |
162 |
9.692e-31 |
4.1e-28 |
12 |
POSITIVE REGULATION OF GENE EXPRESSION |
57 |
1733 |
1.374e-30 |
5.326e-28 |
13 |
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY |
17 |
39 |
9.366e-29 |
3.352e-26 |
14 |
POSITIVE REGULATION OF CELL COMMUNICATION |
52 |
1532 |
3.919e-28 |
1.302e-25 |
15 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
54 |
1710 |
7.853e-28 |
2.436e-25 |
16 |
REGULATION OF ORGAN MORPHOGENESIS |
26 |
242 |
4.847e-26 |
1.41e-23 |
17 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
53 |
1805 |
1.032e-25 |
2.824e-23 |
18 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
44 |
1135 |
1.147e-25 |
2.965e-23 |
19 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
20 |
110 |
6.601e-25 |
1.617e-22 |
20 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
44 |
1192 |
8.391e-25 |
1.952e-22 |
21 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
46 |
1360 |
1.93e-24 |
4.276e-22 |
22 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
49 |
1618 |
4.327e-24 |
9.151e-22 |
23 |
REGULATION OF CELL DIFFERENTIATION |
47 |
1492 |
1.033e-23 |
2.089e-21 |
24 |
TISSUE DEVELOPMENT |
47 |
1518 |
2.148e-23 |
4.165e-21 |
25 |
EPITHELIUM DEVELOPMENT |
38 |
945 |
1.703e-22 |
3.169e-20 |
26 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
49 |
1791 |
3.7e-22 |
6.621e-20 |
27 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
39 |
1036 |
4.311e-22 |
7.164e-20 |
28 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
39 |
1036 |
4.311e-22 |
7.164e-20 |
29 |
TISSUE MORPHOGENESIS |
30 |
533 |
9.54e-22 |
1.531e-19 |
30 |
MORPHOGENESIS OF AN EPITHELIUM |
27 |
400 |
1.267e-21 |
1.966e-19 |
31 |
TUBE MORPHOGENESIS |
25 |
323 |
1.717e-21 |
2.578e-19 |
32 |
INTRACELLULAR SIGNAL TRANSDUCTION |
45 |
1572 |
6.331e-21 |
9.206e-19 |
33 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
46 |
1656 |
6.583e-21 |
9.282e-19 |
34 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
39 |
1142 |
1.369e-20 |
1.874e-18 |
35 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
39 |
1152 |
1.862e-20 |
2.475e-18 |
36 |
REGULATION OF CELL CYCLE |
36 |
949 |
2.016e-20 |
2.606e-18 |
37 |
TUBE DEVELOPMENT |
29 |
552 |
3.404e-20 |
4.168e-18 |
38 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
29 |
552 |
3.404e-20 |
4.168e-18 |
39 |
ORGAN MORPHOGENESIS |
34 |
841 |
4.119e-20 |
4.914e-18 |
40 |
BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY |
11 |
22 |
8.421e-20 |
9.796e-18 |
41 |
REGULATION OF EMBRYONIC DEVELOPMENT |
17 |
114 |
9.663e-20 |
1.097e-17 |
42 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
33 |
823 |
2.131e-19 |
2.361e-17 |
43 |
REGULATION OF CELL PROLIFERATION |
42 |
1496 |
4.291e-19 |
4.643e-17 |
44 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
28 |
554 |
4.684e-19 |
4.953e-17 |
45 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
24 |
365 |
5.432e-19 |
5.617e-17 |
46 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
32 |
788 |
5.823e-19 |
5.765e-17 |
47 |
CIRCULATORY SYSTEM DEVELOPMENT |
32 |
788 |
5.823e-19 |
5.765e-17 |
48 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
45 |
1784 |
9.311e-19 |
9.026e-17 |
49 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
35 |
1004 |
1.143e-18 |
1.085e-16 |
50 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
40 |
1395 |
1.929e-18 |
1.795e-16 |
51 |
EMBRYO DEVELOPMENT |
33 |
894 |
2.576e-18 |
2.351e-16 |
52 |
EMBRYONIC MORPHOGENESIS |
27 |
539 |
2.776e-18 |
2.484e-16 |
53 |
NEURON DIFFERENTIATION |
32 |
874 |
1.196e-17 |
1.05e-15 |
54 |
REGULATION OF PROTEIN LOCALIZATION |
33 |
950 |
1.575e-17 |
1.357e-15 |
55 |
NEUROGENESIS |
39 |
1402 |
1.677e-17 |
1.419e-15 |
56 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
33 |
957 |
1.958e-17 |
1.627e-15 |
57 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
16 |
142 |
1.254e-16 |
1.024e-14 |
58 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
21 |
323 |
1.362e-16 |
1.092e-14 |
59 |
HEART DEVELOPMENT |
24 |
466 |
1.452e-16 |
1.145e-14 |
60 |
PATTERN SPECIFICATION PROCESS |
23 |
418 |
1.609e-16 |
1.248e-14 |
61 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
21 |
337 |
3.205e-16 |
2.445e-14 |
62 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
16 |
152 |
3.777e-16 |
2.834e-14 |
63 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
18 |
220 |
4.357e-16 |
3.218e-14 |
64 |
REGULATION OF RESPONSE TO STRESS |
38 |
1468 |
5.319e-16 |
3.867e-14 |
65 |
REGULATION OF CELL DEATH |
38 |
1472 |
5.813e-16 |
4.161e-14 |
66 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
29 |
801 |
7.322e-16 |
5.162e-14 |
67 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
42 |
1848 |
8.939e-16 |
6.208e-14 |
68 |
REGULATION OF TRANSFERASE ACTIVITY |
31 |
946 |
9.39e-16 |
6.426e-14 |
69 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
15 |
134 |
1.312e-15 |
8.85e-14 |
70 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
27 |
691 |
1.367e-15 |
9.084e-14 |
71 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
38 |
1518 |
1.581e-15 |
1.036e-13 |
72 |
REGULATION OF CELLULAR LOCALIZATION |
35 |
1277 |
1.945e-15 |
1.257e-13 |
73 |
REGULATION OF BINDING |
19 |
283 |
2.424e-15 |
1.545e-13 |
74 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
21 |
381 |
3.727e-15 |
2.343e-13 |
75 |
CELL PROLIFERATION |
26 |
672 |
6.33e-15 |
3.927e-13 |
76 |
PROTEIN PHOSPHORYLATION |
30 |
944 |
6.831e-15 |
4.128e-13 |
77 |
NEURAL TUBE FORMATION |
13 |
94 |
6.803e-15 |
4.128e-13 |
78 |
CELL DEVELOPMENT |
36 |
1426 |
8.651e-15 |
5.16e-13 |
79 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
37 |
1517 |
9.572e-15 |
5.638e-13 |
80 |
CELL FATE COMMITMENT |
17 |
227 |
1.324e-14 |
7.7e-13 |
81 |
REGIONALIZATION |
19 |
311 |
1.355e-14 |
7.786e-13 |
82 |
REGULATION OF JNK CASCADE |
15 |
159 |
1.734e-14 |
9.84e-13 |
83 |
TUBE FORMATION |
14 |
129 |
1.901e-14 |
1.066e-12 |
84 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
15 |
162 |
2.293e-14 |
1.27e-12 |
85 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
16 |
197 |
2.353e-14 |
1.288e-12 |
86 |
NEGATIVE REGULATION OF GENE EXPRESSION |
36 |
1493 |
3.509e-14 |
1.896e-12 |
87 |
REGULATION OF CYTOPLASMIC TRANSPORT |
22 |
481 |
3.546e-14 |
1.896e-12 |
88 |
FC RECEPTOR SIGNALING PATHWAY |
16 |
206 |
4.743e-14 |
2.483e-12 |
89 |
POSITIVE REGULATION OF CELL DEATH |
24 |
605 |
4.749e-14 |
2.483e-12 |
90 |
SENSORY ORGAN DEVELOPMENT |
22 |
493 |
5.848e-14 |
3.023e-12 |
91 |
REGULATION OF CELL CYCLE PROCESS |
23 |
558 |
7.749e-14 |
3.962e-12 |
92 |
REGULATION OF INTRACELLULAR TRANSPORT |
24 |
621 |
8.377e-14 |
4.237e-12 |
93 |
DORSAL VENTRAL AXIS SPECIFICATION |
8 |
20 |
1.033e-13 |
5.169e-12 |
94 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
22 |
513 |
1.306e-13 |
6.466e-12 |
95 |
REGULATION OF CELL DEVELOPMENT |
27 |
836 |
1.364e-13 |
6.682e-12 |
96 |
REGULATION OF PROTEIN IMPORT |
15 |
183 |
1.4e-13 |
6.785e-12 |
97 |
NEURAL TUBE DEVELOPMENT |
14 |
149 |
1.441e-13 |
6.862e-12 |
98 |
REGULATION OF PROTEIN TARGETING |
18 |
307 |
1.445e-13 |
6.862e-12 |
99 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
20 |
406 |
1.487e-13 |
6.987e-12 |
100 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
13 |
119 |
1.568e-13 |
7.295e-12 |
101 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
24 |
643 |
1.779e-13 |
8.198e-12 |
102 |
REGULATION OF KINASE ACTIVITY |
26 |
776 |
1.808e-13 |
8.249e-12 |
103 |
CELL CYCLE |
33 |
1316 |
1.892e-13 |
8.547e-12 |
104 |
CELL CYCLE PROCESS |
30 |
1081 |
2.357e-13 |
1.055e-11 |
105 |
GASTRULATION |
14 |
155 |
2.497e-13 |
1.106e-11 |
106 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
15 |
194 |
3.303e-13 |
1.45e-11 |
107 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
25 |
740 |
4.758e-13 |
2.069e-11 |
108 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE |
7 |
14 |
5.386e-13 |
2.299e-11 |
109 |
CONVERGENT EXTENSION |
7 |
14 |
5.386e-13 |
2.299e-11 |
110 |
REGULATION OF CELL MORPHOGENESIS |
22 |
552 |
5.676e-13 |
2.401e-11 |
111 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
33 |
1381 |
7.21e-13 |
3.022e-11 |
112 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
39 |
1977 |
1.323e-12 |
5.498e-11 |
113 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
29 |
1079 |
1.435e-12 |
5.907e-11 |
114 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
15 |
218 |
1.808e-12 |
7.378e-11 |
115 |
REGULATION OF TRANSPORT |
37 |
1804 |
1.948e-12 |
7.883e-11 |
116 |
REGULATION OF STEM CELL DIFFERENTIATION |
12 |
113 |
1.987e-12 |
7.97e-11 |
117 |
REGULATION OF MITOTIC CELL CYCLE |
20 |
468 |
2.049e-12 |
8.149e-11 |
118 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
18 |
360 |
2.147e-12 |
8.465e-11 |
119 |
REGULATION OF MAPK CASCADE |
23 |
660 |
2.506e-12 |
9.799e-11 |
120 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
25 |
799 |
2.571e-12 |
9.969e-11 |
121 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
26 |
876 |
2.859e-12 |
1.099e-10 |
122 |
CELLULAR RESPONSE TO RETINOIC ACID |
10 |
65 |
3.334e-12 |
1.272e-10 |
123 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
12 |
121 |
4.531e-12 |
1.714e-10 |
124 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
10 |
67 |
4.575e-12 |
1.717e-10 |
125 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
22 |
616 |
4.967e-12 |
1.849e-10 |
126 |
PHOSPHORYLATION |
30 |
1228 |
6.041e-12 |
2.223e-10 |
127 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
27 |
983 |
6.068e-12 |
2.223e-10 |
128 |
POSITIVE REGULATION OF CELL CYCLE |
17 |
332 |
6.357e-12 |
2.311e-10 |
129 |
SENSORY ORGAN MORPHOGENESIS |
15 |
239 |
6.803e-12 |
2.454e-10 |
130 |
MITOTIC CELL CYCLE |
24 |
766 |
7.367e-12 |
2.637e-10 |
131 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
24 |
767 |
7.571e-12 |
2.689e-10 |
132 |
REGULATION OF HYDROLASE ACTIVITY |
31 |
1327 |
7.761e-12 |
2.736e-10 |
133 |
CELL DEATH |
27 |
1001 |
9.212e-12 |
3.22e-10 |
134 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
18 |
393 |
9.273e-12 |
3.22e-10 |
135 |
REGULATION OF ORGANELLE ORGANIZATION |
29 |
1178 |
1.231e-11 |
4.243e-10 |
136 |
CELLULAR RESPONSE TO LIPID |
19 |
457 |
1.248e-11 |
4.269e-10 |
137 |
EMBRYONIC ORGAN DEVELOPMENT |
18 |
406 |
1.589e-11 |
5.397e-10 |
138 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
12 |
135 |
1.676e-11 |
5.649e-10 |
139 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
15 |
258 |
2.028e-11 |
6.739e-10 |
140 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
19 |
470 |
2.024e-11 |
6.739e-10 |
141 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
19 |
472 |
2.178e-11 |
7.187e-10 |
142 |
RESPONSE TO GROWTH FACTOR |
19 |
475 |
2.428e-11 |
7.957e-10 |
143 |
RESPONSE TO LIPID |
25 |
888 |
2.522e-11 |
8.207e-10 |
144 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
56 |
2.791e-11 |
9.017e-10 |
145 |
REGULATION OF IMMUNE SYSTEM PROCESS |
31 |
1403 |
3.211e-11 |
1.03e-09 |
146 |
REGULATION OF JUN KINASE ACTIVITY |
10 |
81 |
3.243e-11 |
1.033e-09 |
147 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
23 |
750 |
3.316e-11 |
1.05e-09 |
148 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
17 |
370 |
3.512e-11 |
1.104e-09 |
149 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
15 |
271 |
4.07e-11 |
1.271e-09 |
150 |
NEGATIVE REGULATION OF CELL CYCLE |
18 |
433 |
4.578e-11 |
1.42e-09 |
151 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
14 |
228 |
4.793e-11 |
1.477e-09 |
152 |
EMBRYONIC ORGAN MORPHOGENESIS |
15 |
279 |
6.135e-11 |
1.878e-09 |
153 |
STEM CELL DIFFERENTIATION |
13 |
190 |
6.373e-11 |
1.938e-09 |
154 |
CELL ACTIVATION |
20 |
568 |
6.712e-11 |
2.028e-09 |
155 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
15 |
282 |
7.131e-11 |
2.141e-09 |
156 |
REGULATION OF IMMUNE RESPONSE |
24 |
858 |
7.723e-11 |
2.304e-09 |
157 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
20 |
573 |
7.84e-11 |
2.324e-09 |
158 |
REGULATION OF PROTEOLYSIS |
22 |
711 |
7.979e-11 |
2.35e-09 |
159 |
SEGMENTATION |
10 |
89 |
8.451e-11 |
2.473e-09 |
160 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
19 |
514 |
9.346e-11 |
2.718e-09 |
161 |
AXIS SPECIFICATION |
10 |
90 |
9.463e-11 |
2.735e-09 |
162 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
7 |
26 |
9.759e-11 |
2.803e-09 |
163 |
BETA CATENIN TCF COMPLEX ASSEMBLY |
8 |
43 |
1.067e-10 |
3.046e-09 |
164 |
NEGATIVE REGULATION OF CELL DEATH |
24 |
872 |
1.075e-10 |
3.051e-09 |
165 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
7 |
27 |
1.311e-10 |
3.698e-09 |
166 |
RHYTHMIC PROCESS |
15 |
298 |
1.546e-10 |
4.332e-09 |
167 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
20 |
609 |
2.294e-10 |
6.392e-09 |
168 |
HEART MORPHOGENESIS |
13 |
212 |
2.495e-10 |
6.911e-09 |
169 |
POSITIVE REGULATION OF KINASE ACTIVITY |
18 |
482 |
2.608e-10 |
7.18e-09 |
170 |
DIGESTIVE TRACT MORPHOGENESIS |
8 |
48 |
2.712e-10 |
7.422e-09 |
171 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
14 |
263 |
3.172e-10 |
8.631e-09 |
172 |
RESPONSE TO DRUG |
17 |
431 |
3.735e-10 |
1.01e-08 |
173 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
8 |
50 |
3.822e-10 |
1.028e-08 |
174 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
15 |
321 |
4.344e-10 |
1.162e-08 |
175 |
FAT CELL DIFFERENTIATION |
10 |
106 |
4.884e-10 |
1.299e-08 |
176 |
RESPONSE TO ABIOTIC STIMULUS |
25 |
1024 |
5.073e-10 |
1.341e-08 |
177 |
INOSITOL PHOSPHATE MEDIATED SIGNALING |
6 |
18 |
5.272e-10 |
1.386e-08 |
178 |
RESPONSE TO RETINOIC ACID |
10 |
107 |
5.362e-10 |
1.402e-08 |
179 |
SOMITE DEVELOPMENT |
9 |
78 |
6.053e-10 |
1.573e-08 |
180 |
DEVELOPMENTAL GROWTH |
15 |
333 |
7.207e-10 |
1.863e-08 |
181 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
7 |
34 |
7.687e-10 |
1.976e-08 |
182 |
REGULATION OF CATABOLIC PROCESS |
21 |
731 |
8.736e-10 |
2.234e-08 |
183 |
MESENCHYME DEVELOPMENT |
12 |
190 |
9.052e-10 |
2.302e-08 |
184 |
POSITIVE REGULATION OF CELL PROLIFERATION |
22 |
814 |
1.022e-09 |
2.585e-08 |
185 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
14 |
289 |
1.085e-09 |
2.728e-08 |
186 |
CELLULAR COMPONENT MORPHOGENESIS |
23 |
900 |
1.182e-09 |
2.956e-08 |
187 |
VASCULATURE DEVELOPMENT |
17 |
469 |
1.351e-09 |
3.361e-08 |
188 |
POSITIVE REGULATION OF MAPK CASCADE |
17 |
470 |
1.395e-09 |
3.453e-08 |
189 |
MIDBRAIN DEVELOPMENT |
9 |
90 |
2.214e-09 |
5.452e-08 |
190 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
21 |
771 |
2.261e-09 |
5.537e-08 |
191 |
SOMITOGENESIS |
8 |
62 |
2.274e-09 |
5.54e-08 |
192 |
DORSAL VENTRAL PATTERN FORMATION |
9 |
91 |
2.446e-09 |
5.927e-08 |
193 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
8 |
63 |
2.593e-09 |
6.251e-08 |
194 |
REGULATION OF GROWTH |
19 |
633 |
3.008e-09 |
7.214e-08 |
195 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
11 |
167 |
3.027e-09 |
7.224e-08 |
196 |
HEAD DEVELOPMENT |
20 |
709 |
3.17e-09 |
7.526e-08 |
197 |
REGULATION OF PROTEIN BINDING |
11 |
168 |
3.224e-09 |
7.616e-08 |
198 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
13 |
263 |
3.481e-09 |
8.18e-08 |
199 |
NEGATIVE REGULATION OF BINDING |
10 |
131 |
3.928e-09 |
9.184e-08 |
200 |
CELLULAR RESPONSE TO ACID CHEMICAL |
11 |
175 |
4.954e-09 |
1.153e-07 |
201 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
13 |
274 |
5.698e-09 |
1.319e-07 |
202 |
REGULATION OF CELL GROWTH |
15 |
391 |
6.401e-09 |
1.475e-07 |
203 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
11 |
181 |
7.053e-09 |
1.617e-07 |
204 |
PEPTIDYL THREONINE MODIFICATION |
7 |
46 |
7.23e-09 |
1.649e-07 |
205 |
RESPONSE TO ENDOGENOUS STIMULUS |
28 |
1450 |
7.36e-09 |
1.671e-07 |
206 |
MACROMOLECULAR COMPLEX DISASSEMBLY |
11 |
182 |
7.471e-09 |
1.687e-07 |
207 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
13 |
285 |
9.126e-09 |
2.051e-07 |
208 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
9 |
106 |
9.545e-09 |
2.135e-07 |
209 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
10 |
144 |
9.826e-09 |
2.188e-07 |
210 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
15 |
404 |
9.923e-09 |
2.199e-07 |
211 |
DOPAMINERGIC NEURON DIFFERENTIATION |
6 |
28 |
1.021e-08 |
2.253e-07 |
212 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
19 |
684 |
1.057e-08 |
2.32e-07 |
213 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
15 |
408 |
1.132e-08 |
2.473e-07 |
214 |
GROWTH |
15 |
410 |
1.208e-08 |
2.627e-07 |
215 |
DIGESTIVE SYSTEM DEVELOPMENT |
10 |
148 |
1.279e-08 |
2.769e-07 |
216 |
POSITIVE REGULATION OF TRANSPORT |
22 |
936 |
1.314e-08 |
2.83e-07 |
217 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
9 |
112 |
1.552e-08 |
3.329e-07 |
218 |
NEGATIVE REGULATION OF PROTEIN BINDING |
8 |
79 |
1.62e-08 |
3.457e-07 |
219 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
12 |
247 |
1.749e-08 |
3.717e-07 |
220 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
11 |
199 |
1.891e-08 |
3.999e-07 |
221 |
POSITIVE REGULATION OF PROTEOLYSIS |
14 |
363 |
1.989e-08 |
4.187e-07 |
222 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
28 |
1527 |
2.257e-08 |
4.73e-07 |
223 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
117 |
2.279e-08 |
4.755e-07 |
224 |
CELL CYCLE PHASE TRANSITION |
12 |
255 |
2.491e-08 |
5.174e-07 |
225 |
OUTFLOW TRACT MORPHOGENESIS |
7 |
56 |
2.989e-08 |
6.181e-07 |
226 |
REGULATION OF CHROMATIN BINDING |
5 |
17 |
3.227e-08 |
6.644e-07 |
227 |
REGULATION OF MAP KINASE ACTIVITY |
13 |
319 |
3.466e-08 |
7.104e-07 |
228 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
12 |
264 |
3.652e-08 |
7.452e-07 |
229 |
CELLULAR COMPONENT DISASSEMBLY |
16 |
515 |
3.744e-08 |
7.606e-07 |
230 |
CELLULAR RESPONSE TO STRESS |
28 |
1565 |
3.816e-08 |
7.721e-07 |
231 |
EMBRYONIC PATTERN SPECIFICATION |
7 |
58 |
3.839e-08 |
7.733e-07 |
232 |
EYE DEVELOPMENT |
13 |
326 |
4.47e-08 |
8.964e-07 |
233 |
CALCIUM MEDIATED SIGNALING |
8 |
90 |
4.569e-08 |
9.084e-07 |
234 |
MESONEPHROS DEVELOPMENT |
8 |
90 |
4.569e-08 |
9.084e-07 |
235 |
NEGATIVE REGULATION OF CELL GROWTH |
10 |
170 |
4.801e-08 |
9.466e-07 |
236 |
SKELETAL SYSTEM DEVELOPMENT |
15 |
455 |
4.784e-08 |
9.466e-07 |
237 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
22 |
1008 |
4.912e-08 |
9.644e-07 |
238 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
10 |
171 |
5.075e-08 |
9.922e-07 |
239 |
REGULATION OF PROTEIN STABILITY |
11 |
221 |
5.553e-08 |
1.081e-06 |
240 |
REGULATION OF CELL SUBSTRATE ADHESION |
10 |
173 |
5.665e-08 |
1.098e-06 |
241 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
9 |
131 |
6.104e-08 |
1.179e-06 |
242 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
15 |
465 |
6.356e-08 |
1.221e-06 |
243 |
LOCOMOTION |
23 |
1114 |
6.374e-08 |
1.221e-06 |
244 |
REGULATION OF CHROMOSOME ORGANIZATION |
12 |
278 |
6.436e-08 |
1.227e-06 |
245 |
REGULATION OF MUSCLE ADAPTATION |
7 |
63 |
6.901e-08 |
1.311e-06 |
246 |
WOUND HEALING |
15 |
470 |
7.306e-08 |
1.382e-06 |
247 |
MESENCHYMAL CELL DIFFERENTIATION |
9 |
134 |
7.426e-08 |
1.399e-06 |
248 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
20 |
872 |
9.858e-08 |
1.85e-06 |
249 |
COCHLEA MORPHOGENESIS |
5 |
21 |
1.042e-07 |
1.947e-06 |
250 |
NEGATIVE REGULATION OF GROWTH |
11 |
236 |
1.083e-07 |
2.015e-06 |
251 |
REGULATION OF CELL JUNCTION ASSEMBLY |
7 |
68 |
1.181e-07 |
2.181e-06 |
252 |
POSITIVE REGULATION OF GROWTH |
11 |
238 |
1.179e-07 |
2.181e-06 |
253 |
RESPONSE TO WOUNDING |
16 |
563 |
1.269e-07 |
2.334e-06 |
254 |
IMMUNE SYSTEM PROCESS |
31 |
1984 |
1.311e-07 |
2.401e-06 |
255 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
8 |
103 |
1.318e-07 |
2.405e-06 |
256 |
POSITIVE REGULATION OF PROTEIN IMPORT |
8 |
104 |
1.421e-07 |
2.583e-06 |
257 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
18 |
724 |
1.429e-07 |
2.587e-06 |
258 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
6 |
43 |
1.542e-07 |
2.781e-06 |
259 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
13 |
363 |
1.556e-07 |
2.795e-06 |
260 |
MUSCLE STRUCTURE DEVELOPMENT |
14 |
432 |
1.71e-07 |
3.048e-06 |
261 |
SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
5 |
23 |
1.708e-07 |
3.048e-06 |
262 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
9 |
148 |
1.745e-07 |
3.088e-06 |
263 |
PEPTIDYL SERINE MODIFICATION |
9 |
148 |
1.745e-07 |
3.088e-06 |
264 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
20 |
905 |
1.793e-07 |
3.16e-06 |
265 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
22 |
1087 |
1.828e-07 |
3.21e-06 |
266 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
10 |
197 |
1.915e-07 |
3.35e-06 |
267 |
FORMATION OF PRIMARY GERM LAYER |
8 |
110 |
2.197e-07 |
3.829e-06 |
268 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
20 |
917 |
2.213e-07 |
3.843e-06 |
269 |
LEUKOCYTE CELL CELL ADHESION |
11 |
255 |
2.36e-07 |
4.083e-06 |
270 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
9 |
154 |
2.45e-07 |
4.222e-06 |
271 |
REGULATION OF CELLULAR RESPONSE TO HEAT |
7 |
76 |
2.566e-07 |
4.405e-06 |
272 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
7 |
77 |
2.809e-07 |
4.805e-06 |
273 |
RESPONSE TO ACID CHEMICAL |
12 |
319 |
2.849e-07 |
4.856e-06 |
274 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
16 |
602 |
3.128e-07 |
5.312e-06 |
275 |
CELL CELL SIGNALING |
18 |
767 |
3.342e-07 |
5.655e-06 |
276 |
SECOND MESSENGER MEDIATED SIGNALING |
9 |
160 |
3.39e-07 |
5.715e-06 |
277 |
SINGLE ORGANISM CELL ADHESION |
14 |
459 |
3.561e-07 |
5.981e-06 |
278 |
MESODERM DEVELOPMENT |
8 |
118 |
3.778e-07 |
6.323e-06 |
279 |
DEVELOPMENTAL INDUCTION |
5 |
27 |
4.023e-07 |
6.685e-06 |
280 |
AXIS ELONGATION |
5 |
27 |
4.023e-07 |
6.685e-06 |
281 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
13 |
395 |
4.082e-07 |
6.76e-06 |
282 |
APPENDAGE DEVELOPMENT |
9 |
169 |
5.382e-07 |
8.849e-06 |
283 |
LIMB DEVELOPMENT |
9 |
169 |
5.382e-07 |
8.849e-06 |
284 |
PALATE DEVELOPMENT |
7 |
85 |
5.554e-07 |
9.099e-06 |
285 |
REGULATION OF CELL ADHESION |
16 |
629 |
5.608e-07 |
9.155e-06 |
286 |
KIDNEY EPITHELIUM DEVELOPMENT |
8 |
125 |
5.877e-07 |
9.562e-06 |
287 |
RESPONSE TO CYTOKINE |
17 |
714 |
6.025e-07 |
9.768e-06 |
288 |
RESPONSE TO UV |
8 |
126 |
6.246e-07 |
1.009e-05 |
289 |
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY |
4 |
13 |
6.88e-07 |
1.108e-05 |
290 |
REGULATION OF STEM CELL PROLIFERATION |
7 |
88 |
7.043e-07 |
1.13e-05 |
291 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
8 |
129 |
7.474e-07 |
1.195e-05 |
292 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
10 |
229 |
7.661e-07 |
1.221e-05 |
293 |
APOPTOTIC SIGNALING PATHWAY |
11 |
289 |
8.168e-07 |
1.297e-05 |
294 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
5 |
31 |
8.315e-07 |
1.312e-05 |
295 |
REGULATION OF OSSIFICATION |
9 |
178 |
8.319e-07 |
1.312e-05 |
296 |
RESPONSE TO EXTERNAL STIMULUS |
28 |
1821 |
8.736e-07 |
1.373e-05 |
297 |
EPITHELIAL CELL DIFFERENTIATION |
14 |
495 |
8.772e-07 |
1.374e-05 |
298 |
INNER EAR MORPHOGENESIS |
7 |
92 |
9.539e-07 |
1.489e-05 |
299 |
PROTEIN CATABOLIC PROCESS |
15 |
579 |
1.042e-06 |
1.621e-05 |
300 |
RESPONSE TO ALCOHOL |
12 |
362 |
1.087e-06 |
1.685e-05 |
301 |
EYE MORPHOGENESIS |
8 |
136 |
1.117e-06 |
1.726e-05 |
302 |
UROGENITAL SYSTEM DEVELOPMENT |
11 |
299 |
1.14e-06 |
1.756e-05 |
303 |
EMBRYONIC AXIS SPECIFICATION |
5 |
33 |
1.151e-06 |
1.762e-05 |
304 |
BLOOD VESSEL MORPHOGENESIS |
12 |
364 |
1.151e-06 |
1.762e-05 |
305 |
CHONDROCYTE DIFFERENTIATION |
6 |
60 |
1.17e-06 |
1.78e-05 |
306 |
REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY |
6 |
60 |
1.17e-06 |
1.78e-05 |
307 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
7 |
95 |
1.186e-06 |
1.787e-05 |
308 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
7 |
95 |
1.186e-06 |
1.787e-05 |
309 |
CELLULAR RESPONSE TO RADIATION |
8 |
137 |
1.18e-06 |
1.787e-05 |
310 |
EMBRYONIC DIGIT MORPHOGENESIS |
6 |
61 |
1.292e-06 |
1.939e-05 |
311 |
MITOTIC CELL CYCLE CHECKPOINT |
8 |
139 |
1.317e-06 |
1.97e-05 |
312 |
REGULATION OF PROTEIN DEACETYLATION |
5 |
34 |
1.343e-06 |
1.99e-05 |
313 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
5 |
34 |
1.343e-06 |
1.99e-05 |
314 |
PROTEIN DESTABILIZATION |
5 |
34 |
1.343e-06 |
1.99e-05 |
315 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
6 |
62 |
1.424e-06 |
2.103e-05 |
316 |
PROTEIN DEPHOSPHORYLATION |
9 |
190 |
1.433e-06 |
2.11e-05 |
317 |
REGULATION OF EPIDERMIS DEVELOPMENT |
6 |
63 |
1.567e-06 |
2.299e-05 |
318 |
IN UTERO EMBRYONIC DEVELOPMENT |
11 |
311 |
1.672e-06 |
2.447e-05 |
319 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
7 |
100 |
1.679e-06 |
2.449e-05 |
320 |
RESPONSE TO NITROGEN COMPOUND |
18 |
859 |
1.706e-06 |
2.473e-05 |
321 |
CONNECTIVE TISSUE DEVELOPMENT |
9 |
194 |
1.703e-06 |
2.473e-05 |
322 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
11 |
312 |
1.725e-06 |
2.49e-05 |
323 |
PARAXIAL MESODERM DEVELOPMENT |
4 |
16 |
1.728e-06 |
2.49e-05 |
324 |
CAMERA TYPE EYE MORPHOGENESIS |
7 |
101 |
1.796e-06 |
2.579e-05 |
325 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
36 |
1.803e-06 |
2.582e-05 |
326 |
RESPIRATORY SYSTEM DEVELOPMENT |
9 |
197 |
1.933e-06 |
2.759e-05 |
327 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
18 |
867 |
1.945e-06 |
2.768e-05 |
328 |
CELLULAR RESPONSE TO UV |
6 |
66 |
2.066e-06 |
2.887e-05 |
329 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
7 |
103 |
2.049e-06 |
2.887e-05 |
330 |
REGULATION OF CIRCADIAN RHYTHM |
7 |
103 |
2.049e-06 |
2.887e-05 |
331 |
MESODERM MORPHOGENESIS |
6 |
66 |
2.066e-06 |
2.887e-05 |
332 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
7 |
103 |
2.049e-06 |
2.887e-05 |
333 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
6 |
66 |
2.066e-06 |
2.887e-05 |
334 |
NEGATIVE REGULATION OF TRANSPORT |
13 |
458 |
2.132e-06 |
2.97e-05 |
335 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
7 |
104 |
2.187e-06 |
3.037e-05 |
336 |
REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS |
4 |
17 |
2.25e-06 |
3.098e-05 |
337 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
2.25e-06 |
3.098e-05 |
338 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
15 |
616 |
2.24e-06 |
3.098e-05 |
339 |
SKELETAL SYSTEM MORPHOGENESIS |
9 |
201 |
2.281e-06 |
3.131e-05 |
340 |
MESENCHYME MORPHOGENESIS |
5 |
38 |
2.379e-06 |
3.256e-05 |
341 |
REGULATION OF FAT CELL DIFFERENTIATION |
7 |
106 |
2.485e-06 |
3.374e-05 |
342 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
14 |
541 |
2.487e-06 |
3.374e-05 |
343 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
14 |
541 |
2.487e-06 |
3.374e-05 |
344 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
9 |
204 |
2.577e-06 |
3.485e-05 |
345 |
GLAND DEVELOPMENT |
12 |
395 |
2.688e-06 |
3.625e-05 |
346 |
NEURON PROJECTION DEVELOPMENT |
14 |
545 |
2.709e-06 |
3.643e-05 |
347 |
COCHLEA DEVELOPMENT |
5 |
39 |
2.717e-06 |
3.643e-05 |
348 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
7 |
108 |
2.817e-06 |
3.767e-05 |
349 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
9 |
207 |
2.905e-06 |
3.873e-05 |
350 |
REGULATION OF MEMBRANE PERMEABILITY |
6 |
70 |
2.927e-06 |
3.891e-05 |
351 |
RESPONSE TO HORMONE |
18 |
893 |
2.946e-06 |
3.905e-05 |
352 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
5 |
40 |
3.091e-06 |
4.086e-05 |
353 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
9 |
209 |
3.143e-06 |
4.143e-05 |
354 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
6 |
71 |
3.182e-06 |
4.183e-05 |
355 |
REGULATION OF NEURON DIFFERENTIATION |
14 |
554 |
3.274e-06 |
4.291e-05 |
356 |
RESPONSE TO INORGANIC SUBSTANCE |
13 |
479 |
3.482e-06 |
4.552e-05 |
357 |
REPRODUCTION |
22 |
1297 |
3.5e-06 |
4.562e-05 |
358 |
EAR MORPHOGENESIS |
7 |
112 |
3.592e-06 |
4.669e-05 |
359 |
POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS |
4 |
19 |
3.633e-06 |
4.708e-05 |
360 |
LYMPHOCYTE ACTIVATION |
11 |
342 |
4.172e-06 |
5.393e-05 |
361 |
RESPONSE TO RADIATION |
12 |
413 |
4.244e-06 |
5.47e-05 |
362 |
LEUKOCYTE ACTIVATION |
12 |
414 |
4.35e-06 |
5.591e-05 |
363 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
5 |
43 |
4.461e-06 |
5.702e-05 |
364 |
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
43 |
4.461e-06 |
5.702e-05 |
365 |
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
20 |
4.521e-06 |
5.763e-05 |
366 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
17 |
829 |
4.565e-06 |
5.803e-05 |
367 |
POSITIVE REGULATION OF LOCOMOTION |
12 |
420 |
5.036e-06 |
6.385e-05 |
368 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
8 |
167 |
5.188e-06 |
6.56e-05 |
369 |
CHROMATIN ORGANIZATION |
15 |
663 |
5.47e-06 |
6.898e-05 |
370 |
POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
4 |
21 |
5.56e-06 |
6.992e-05 |
371 |
PROTEIN COMPLEX BIOGENESIS |
20 |
1132 |
5.722e-06 |
7.157e-05 |
372 |
PROTEIN COMPLEX ASSEMBLY |
20 |
1132 |
5.722e-06 |
7.157e-05 |
373 |
REGULATION OF CYTOSKELETON ORGANIZATION |
13 |
502 |
5.789e-06 |
7.221e-05 |
374 |
ACTIVATION OF IMMUNE RESPONSE |
12 |
427 |
5.956e-06 |
7.41e-05 |
375 |
REGULATION OF DEVELOPMENTAL GROWTH |
10 |
289 |
6.159e-06 |
7.641e-05 |
376 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
7 |
122 |
6.339e-06 |
7.844e-05 |
377 |
SOMATIC STEM CELL DIVISION |
4 |
22 |
6.766e-06 |
8.35e-05 |
378 |
REGULATION OF FIBROBLAST PROLIFERATION |
6 |
81 |
6.885e-06 |
8.475e-05 |
379 |
ANGIOGENESIS |
10 |
293 |
6.948e-06 |
8.53e-05 |
380 |
KIDNEY MORPHOGENESIS |
6 |
82 |
7.394e-06 |
9.054e-05 |
381 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
5 |
48 |
7.757e-06 |
9.449e-05 |
382 |
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
5 |
48 |
7.757e-06 |
9.449e-05 |
383 |
RESPONSE TO EXTRACELLULAR STIMULUS |
12 |
441 |
8.249e-06 |
0.0001002 |
384 |
REGULATION OF PHOSPHATASE ACTIVITY |
7 |
128 |
8.698e-06 |
0.0001051 |
385 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION |
7 |
128 |
8.698e-06 |
0.0001051 |
386 |
MUSCLE CELL DIFFERENTIATION |
9 |
237 |
8.716e-06 |
0.0001051 |
387 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
10 |
303 |
9.317e-06 |
0.0001117 |
388 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
10 |
303 |
9.317e-06 |
0.0001117 |
389 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
5 |
50 |
9.512e-06 |
0.0001138 |
390 |
REGULATION OF HISTONE DEACETYLATION |
4 |
24 |
9.742e-06 |
0.0001153 |
391 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
4 |
24 |
9.742e-06 |
0.0001153 |
392 |
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY |
4 |
24 |
9.742e-06 |
0.0001153 |
393 |
REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY |
4 |
24 |
9.742e-06 |
0.0001153 |
394 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
11 |
375 |
9.969e-06 |
0.0001177 |
395 |
PROTEIN STABILIZATION |
7 |
131 |
1.013e-05 |
0.0001193 |
396 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
5 |
51 |
1.05e-05 |
0.000123 |
397 |
POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
5 |
51 |
1.05e-05 |
0.000123 |
398 |
MAINTENANCE OF CELL NUMBER |
7 |
132 |
1.064e-05 |
0.0001244 |
399 |
RESPONSE TO OXYGEN LEVELS |
10 |
311 |
1.169e-05 |
0.0001363 |
400 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
9 |
246 |
1.175e-05 |
0.0001367 |
401 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
7 |
135 |
1.233e-05 |
0.000143 |
402 |
CHROMATIN MODIFICATION |
13 |
539 |
1.237e-05 |
0.0001432 |
403 |
REGULATION OF CELL MATRIX ADHESION |
6 |
90 |
1.267e-05 |
0.0001463 |
404 |
MESONEPHRIC TUBULE MORPHOGENESIS |
5 |
53 |
1.271e-05 |
0.0001464 |
405 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
8 |
190 |
1.335e-05 |
0.0001533 |
406 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
6 |
91 |
1.35e-05 |
0.0001547 |
407 |
CELL PROJECTION ORGANIZATION |
17 |
902 |
1.377e-05 |
0.0001574 |
408 |
CELL CYCLE G2 M PHASE TRANSITION |
7 |
138 |
1.423e-05 |
0.0001623 |
409 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
8 |
192 |
1.44e-05 |
0.000163 |
410 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
6 |
92 |
1.438e-05 |
0.000163 |
411 |
PROTEIN AUTOPHOSPHORYLATION |
8 |
192 |
1.44e-05 |
0.000163 |
412 |
PROTEOLYSIS |
20 |
1208 |
1.487e-05 |
0.000168 |
413 |
CELL CYCLE CHECKPOINT |
8 |
194 |
1.552e-05 |
0.0001749 |
414 |
CHROMOSOME ORGANIZATION |
18 |
1009 |
1.57e-05 |
0.0001765 |
415 |
RESPONSE TO LITHIUM ION |
4 |
27 |
1.588e-05 |
0.000178 |
416 |
REGULATION OF MUSCLE SYSTEM PROCESS |
8 |
195 |
1.611e-05 |
0.0001802 |
417 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
6 |
95 |
1.728e-05 |
0.0001929 |
418 |
REGULATION OF CELL PROJECTION ORGANIZATION |
13 |
558 |
1.783e-05 |
0.0001985 |
419 |
CARDIAC CHAMBER DEVELOPMENT |
7 |
144 |
1.876e-05 |
0.0002083 |
420 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
9 |
262 |
1.938e-05 |
0.0002147 |
421 |
REGULATION OF CYTOKINE PRODUCTION |
13 |
563 |
1.958e-05 |
0.0002158 |
422 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
13 |
563 |
1.958e-05 |
0.0002158 |
423 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
7 |
146 |
2.051e-05 |
0.0002256 |
424 |
RESPONSE TO METAL ION |
10 |
333 |
2.106e-05 |
0.0002311 |
425 |
REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
4 |
29 |
2.13e-05 |
0.0002316 |
426 |
POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
4 |
29 |
2.13e-05 |
0.0002316 |
427 |
STEM CELL DIVISION |
4 |
29 |
2.13e-05 |
0.0002316 |
428 |
BIOLOGICAL ADHESION |
18 |
1032 |
2.121e-05 |
0.0002316 |
429 |
CARTILAGE DEVELOPMENT |
7 |
147 |
2.143e-05 |
0.0002319 |
430 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
7 |
147 |
2.143e-05 |
0.0002319 |
431 |
SEX DIFFERENTIATION |
9 |
266 |
2.184e-05 |
0.0002356 |
432 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
6 |
99 |
2.188e-05 |
0.0002356 |
433 |
POSITIVE REGULATION OF CELL GROWTH |
7 |
148 |
2.239e-05 |
0.0002406 |
434 |
STEM CELL PROLIFERATION |
5 |
60 |
2.343e-05 |
0.0002512 |
435 |
PROTEIN LOCALIZATION |
25 |
1805 |
2.369e-05 |
0.0002534 |
436 |
RESPONSE TO X RAY |
4 |
30 |
2.447e-05 |
0.0002612 |
437 |
REGULATION OF CHROMATIN ORGANIZATION |
7 |
152 |
2.659e-05 |
0.0002831 |
438 |
RESPONSE TO MECHANICAL STIMULUS |
8 |
210 |
2.744e-05 |
0.0002916 |
439 |
IMMUNE SYSTEM DEVELOPMENT |
13 |
582 |
2.766e-05 |
0.0002932 |
440 |
COVALENT CHROMATIN MODIFICATION |
10 |
345 |
2.848e-05 |
0.0003012 |
441 |
POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS |
3 |
11 |
2.879e-05 |
0.0003037 |
442 |
CARDIAC CHAMBER MORPHOGENESIS |
6 |
104 |
2.895e-05 |
0.000304 |
443 |
CELL CYCLE ARREST |
7 |
154 |
2.892e-05 |
0.000304 |
444 |
REGULATION OF CARTILAGE DEVELOPMENT |
5 |
63 |
2.975e-05 |
0.0003111 |
445 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
11 |
422 |
2.972e-05 |
0.0003111 |
446 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
8 |
213 |
3.037e-05 |
0.0003168 |
447 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
8 |
214 |
3.14e-05 |
0.0003263 |
448 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
7 |
156 |
3.142e-05 |
0.0003263 |
449 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
12 |
505 |
3.155e-05 |
0.0003269 |
450 |
PATTERNING OF BLOOD VESSELS |
4 |
32 |
3.183e-05 |
0.0003284 |
451 |
EMBRYONIC FORELIMB MORPHOGENESIS |
4 |
32 |
3.183e-05 |
0.0003284 |
452 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
20 |
1275 |
3.226e-05 |
0.000332 |
453 |
RESPONSE TO LIGHT STIMULUS |
9 |
280 |
3.266e-05 |
0.0003355 |
454 |
REGULATION OF DEPHOSPHORYLATION |
7 |
158 |
3.409e-05 |
0.0003494 |
455 |
REGULATION OF MITOCHONDRION ORGANIZATION |
8 |
218 |
3.583e-05 |
0.0003657 |
456 |
REGULATION OF CELL CYCLE ARREST |
6 |
108 |
3.584e-05 |
0.0003657 |
457 |
REGULATION OF PROTEIN EXPORT FROM NUCLEUS |
4 |
33 |
3.606e-05 |
0.0003664 |
458 |
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT |
4 |
33 |
3.606e-05 |
0.0003664 |
459 |
NEURON DEVELOPMENT |
14 |
687 |
3.66e-05 |
0.000371 |
460 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
5 |
66 |
3.731e-05 |
0.0003774 |
461 |
MACROMOLECULAR COMPLEX ASSEMBLY |
21 |
1398 |
3.76e-05 |
0.0003795 |
462 |
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION |
3 |
12 |
3.822e-05 |
0.0003841 |
463 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
3 |
12 |
3.822e-05 |
0.0003841 |
464 |
DEPHOSPHORYLATION |
9 |
286 |
3.853e-05 |
0.0003864 |
465 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
5 |
67 |
4.014e-05 |
4e-04 |
466 |
CELLULAR RESPONSE TO DRUG |
5 |
67 |
4.014e-05 |
4e-04 |
467 |
REGULATION OF SISTER CHROMATID SEGREGATION |
5 |
67 |
4.014e-05 |
4e-04 |
468 |
BRAIN MORPHOGENESIS |
4 |
34 |
4.069e-05 |
0.0004045 |
469 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
11 |
437 |
4.083e-05 |
0.000405 |
470 |
CELL CYCLE G1 S PHASE TRANSITION |
6 |
111 |
4.182e-05 |
0.0004132 |
471 |
G1 S TRANSITION OF MITOTIC CELL CYCLE |
6 |
111 |
4.182e-05 |
0.0004132 |
472 |
CELL CELL ADHESION |
13 |
608 |
4.341e-05 |
0.0004279 |
473 |
BONE REMODELING |
4 |
35 |
4.574e-05 |
0.0004499 |
474 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
7 |
166 |
4.671e-05 |
0.0004585 |
475 |
WHITE FAT CELL DIFFERENTIATION |
3 |
13 |
4.948e-05 |
0.0004807 |
476 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
3 |
13 |
4.948e-05 |
0.0004807 |
477 |
REGULATION OF SKELETAL MUSCLE ADAPTATION |
3 |
13 |
4.948e-05 |
0.0004807 |
478 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
10 |
368 |
4.91e-05 |
0.0004807 |
479 |
REGULATION OF CELL FATE SPECIFICATION |
3 |
13 |
4.948e-05 |
0.0004807 |
480 |
NEURAL PRECURSOR CELL PROLIFERATION |
5 |
70 |
4.963e-05 |
0.0004811 |
481 |
RESPONSE TO CARBOHYDRATE |
7 |
168 |
5.04e-05 |
0.0004876 |
482 |
CELLULAR RESPONSE TO ALCOHOL |
6 |
115 |
5.102e-05 |
0.0004915 |
483 |
NEPHRON DEVELOPMENT |
6 |
115 |
5.102e-05 |
0.0004915 |
484 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
10 |
370 |
5.138e-05 |
0.000494 |
485 |
ENDODERM DEVELOPMENT |
5 |
71 |
5.315e-05 |
0.0005099 |
486 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
6 |
117 |
5.619e-05 |
0.000538 |
487 |
REGULATION OF MUSCLE HYPERTROPHY |
4 |
37 |
5.719e-05 |
0.0005464 |
488 |
REGULATION OF VASCULATURE DEVELOPMENT |
8 |
233 |
5.734e-05 |
0.0005467 |
489 |
POSITIVE REGULATION OF CELL ADHESION |
10 |
376 |
5.877e-05 |
0.0005593 |
490 |
REGULATION OF MONOCYTE DIFFERENTIATION |
3 |
14 |
6.272e-05 |
0.0005955 |
491 |
CELL DIVISION |
11 |
460 |
6.476e-05 |
0.0006137 |
492 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
7 |
175 |
6.525e-05 |
0.0006171 |
493 |
MITOCHONDRIAL TRANSPORT |
7 |
177 |
7.01e-05 |
0.0006602 |
494 |
TAXIS |
11 |
464 |
6.997e-05 |
0.0006602 |
495 |
MACROMOLECULE CATABOLIC PROCESS |
16 |
926 |
7.144e-05 |
0.0006715 |
496 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
12 |
552 |
7.424e-05 |
0.0006953 |
497 |
T CELL DIFFERENTIATION |
6 |
123 |
7.427e-05 |
0.0006953 |
498 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
3 |
15 |
7.807e-05 |
0.0007268 |
499 |
FORELIMB MORPHOGENESIS |
4 |
40 |
7.81e-05 |
0.0007268 |
500 |
REGULATION OF MESODERM DEVELOPMENT |
3 |
15 |
7.807e-05 |
0.0007268 |
501 |
REGULATION OF BMP SIGNALING PATHWAY |
5 |
77 |
7.849e-05 |
0.000729 |
502 |
CELL MOTILITY |
15 |
835 |
7.962e-05 |
0.0007366 |
503 |
LOCALIZATION OF CELL |
15 |
835 |
7.962e-05 |
0.0007366 |
504 |
RENAL TUBULE DEVELOPMENT |
5 |
78 |
8.349e-05 |
0.0007708 |
505 |
OSTEOBLAST DIFFERENTIATION |
6 |
126 |
8.49e-05 |
0.0007807 |
506 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
6 |
126 |
8.49e-05 |
0.0007807 |
507 |
PEPTIDYL AMINO ACID MODIFICATION |
15 |
841 |
8.624e-05 |
0.0007915 |
508 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
7 |
183 |
8.642e-05 |
0.0007916 |
509 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
6 |
128 |
9.263e-05 |
0.0008435 |
510 |
CELL JUNCTION ORGANIZATION |
7 |
185 |
9.25e-05 |
0.0008435 |
511 |
MUSCLE CELL DEVELOPMENT |
6 |
128 |
9.263e-05 |
0.0008435 |
512 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
8 |
250 |
9.376e-05 |
0.0008521 |
513 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
5 |
80 |
9.421e-05 |
0.0008545 |
514 |
MORPHOGENESIS OF AN ENDOTHELIUM |
3 |
16 |
9.569e-05 |
0.0008645 |
515 |
ORGAN INDUCTION |
3 |
16 |
9.569e-05 |
0.0008645 |
516 |
OSSIFICATION |
8 |
251 |
9.639e-05 |
0.0008692 |
517 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
7 |
188 |
0.0001023 |
0.0009188 |
518 |
NEURON PROJECTION MORPHOGENESIS |
10 |
402 |
0.0001022 |
0.0009188 |
519 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
4 |
43 |
0.0001041 |
0.0009314 |
520 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
43 |
0.0001041 |
0.0009314 |
521 |
REGULATION OF PEPTIDE TRANSPORT |
8 |
256 |
0.0001105 |
0.0009868 |
522 |
NIK NF KAPPAB SIGNALING |
5 |
83 |
0.0001123 |
0.001001 |
523 |
LABYRINTHINE LAYER DEVELOPMENT |
4 |
44 |
0.000114 |
0.001012 |
524 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
4 |
44 |
0.000114 |
0.001012 |
525 |
CELLULAR RESPONSE TO LITHIUM ION |
3 |
17 |
0.0001157 |
0.001022 |
526 |
ESTABLISHMENT OF TISSUE POLARITY |
3 |
17 |
0.0001157 |
0.001022 |
527 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
10 |
408 |
0.0001154 |
0.001022 |
528 |
POSITIVE REGULATION OF OSSIFICATION |
5 |
84 |
0.0001188 |
0.001047 |
529 |
REGULATION OF GTPASE ACTIVITY |
13 |
673 |
0.0001209 |
0.001063 |
530 |
THYMOCYTE AGGREGATION |
4 |
45 |
0.0001246 |
0.001092 |
531 |
T CELL DIFFERENTIATION IN THYMUS |
4 |
45 |
0.0001246 |
0.001092 |
532 |
CARDIAC SEPTUM DEVELOPMENT |
5 |
85 |
0.0001257 |
0.001093 |
533 |
REGULATION OF CHROMOSOME SEGREGATION |
5 |
85 |
0.0001257 |
0.001093 |
534 |
POSITIVE REGULATION OF CHROMATIN MODIFICATION |
5 |
85 |
0.0001257 |
0.001093 |
535 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
5 |
85 |
0.0001257 |
0.001093 |
536 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
7 |
195 |
0.0001284 |
0.001113 |
537 |
EAR DEVELOPMENT |
7 |
195 |
0.0001284 |
0.001113 |
538 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
6 |
136 |
0.0001294 |
0.001119 |
539 |
NEGATIVE REGULATION OF LOCOMOTION |
8 |
263 |
0.0001331 |
0.001149 |
540 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
4 |
46 |
0.0001358 |
0.00117 |
541 |
REGULATION OF CELL MATURATION |
3 |
18 |
0.0001383 |
0.001181 |
542 |
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
18 |
1193 |
0.0001377 |
0.001181 |
543 |
PERICARDIUM DEVELOPMENT |
3 |
18 |
0.0001383 |
0.001181 |
544 |
POST ANAL TAIL MORPHOGENESIS |
3 |
18 |
0.0001383 |
0.001181 |
545 |
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION |
3 |
18 |
0.0001383 |
0.001181 |
546 |
PLACENTA DEVELOPMENT |
6 |
138 |
0.0001401 |
0.001194 |
547 |
REGULATION OF DNA METABOLIC PROCESS |
9 |
340 |
0.0001445 |
0.001229 |
548 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
5 |
88 |
0.0001481 |
0.001255 |
549 |
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS |
4 |
47 |
0.0001478 |
0.001255 |
550 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
6 |
141 |
0.0001576 |
0.001334 |
551 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
3 |
19 |
0.0001635 |
0.001381 |
552 |
PLATELET ACTIVATION |
6 |
142 |
0.0001638 |
0.001381 |
553 |
ENDOTHELIUM DEVELOPMENT |
5 |
90 |
0.0001646 |
0.001385 |
554 |
REGULATION OF CELL DIVISION |
8 |
272 |
0.0001676 |
0.001407 |
555 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
6 |
143 |
0.0001702 |
0.001422 |
556 |
RAS PROTEIN SIGNAL TRANSDUCTION |
6 |
143 |
0.0001702 |
0.001422 |
557 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
6 |
143 |
0.0001702 |
0.001422 |
558 |
CARDIAC SEPTUM MORPHOGENESIS |
4 |
49 |
0.0001741 |
0.001451 |
559 |
NEURON PROJECTION GUIDANCE |
7 |
205 |
0.0001749 |
0.001455 |
560 |
MEMBRANE ORGANIZATION |
15 |
899 |
0.0001795 |
0.001492 |
561 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
9 |
351 |
0.0001833 |
0.00152 |
562 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
9 |
352 |
0.0001872 |
0.00155 |
563 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
4 |
50 |
0.0001884 |
0.001554 |
564 |
RHO PROTEIN SIGNAL TRANSDUCTION |
4 |
50 |
0.0001884 |
0.001554 |
565 |
TONGUE DEVELOPMENT |
3 |
20 |
0.0001916 |
0.001573 |
566 |
NEPHRON EPITHELIUM DEVELOPMENT |
5 |
93 |
0.0001921 |
0.001573 |
567 |
REGULATION OF DNA BINDING |
5 |
93 |
0.0001921 |
0.001573 |
568 |
TRACHEA DEVELOPMENT |
3 |
20 |
0.0001916 |
0.001573 |
569 |
LYMPHOCYTE DIFFERENTIATION |
7 |
209 |
0.0001969 |
0.00161 |
570 |
MALE SEX DIFFERENTIATION |
6 |
148 |
0.0002052 |
0.001675 |
571 |
REGULATION OF INNATE IMMUNE RESPONSE |
9 |
357 |
0.0002079 |
0.001691 |
572 |
FOREBRAIN DEVELOPMENT |
9 |
357 |
0.0002079 |
0.001691 |
573 |
SKIN DEVELOPMENT |
7 |
211 |
0.0002087 |
0.001695 |
574 |
BONE RESORPTION |
3 |
21 |
0.0002226 |
0.001804 |
575 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
4 |
53 |
0.0002364 |
0.001908 |
576 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
4 |
53 |
0.0002364 |
0.001908 |
577 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
6 |
152 |
0.000237 |
0.001908 |
578 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
152 |
0.000237 |
0.001908 |
579 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
9 |
364 |
0.0002401 |
0.001929 |
580 |
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
5 |
98 |
0.0002454 |
0.001967 |
581 |
PALLIUM DEVELOPMENT |
6 |
153 |
0.0002456 |
0.001967 |
582 |
MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
3 |
22 |
0.0002567 |
0.002041 |
583 |
POSITIVE REGULATION OF MUSCLE HYPERTROPHY |
3 |
22 |
0.0002567 |
0.002041 |
584 |
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY |
3 |
22 |
0.0002567 |
0.002041 |
585 |
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
3 |
22 |
0.0002567 |
0.002041 |
586 |
LEUKOCYTE DIFFERENTIATION |
8 |
292 |
0.000271 |
0.002152 |
587 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
4 |
56 |
0.0002926 |
0.00232 |
588 |
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
3 |
23 |
0.0002939 |
0.002322 |
589 |
REGULATION OF OSTEOBLAST PROLIFERATION |
3 |
23 |
0.0002939 |
0.002322 |
590 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
5 |
102 |
0.0002955 |
0.002331 |
591 |
MYOTUBE DIFFERENTIATION |
4 |
57 |
0.0003133 |
0.002463 |
592 |
APOPTOTIC MITOCHONDRIAL CHANGES |
4 |
57 |
0.0003133 |
0.002463 |
593 |
REGENERATION |
6 |
161 |
0.000323 |
0.00253 |
594 |
REGULATION OF DNA REPLICATION |
6 |
161 |
0.000323 |
0.00253 |
595 |
MODULATION OF SYNAPTIC TRANSMISSION |
8 |
301 |
0.0003322 |
0.002598 |
596 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
3 |
24 |
0.0003345 |
0.002612 |
597 |
CEREBRAL CORTEX DEVELOPMENT |
5 |
105 |
0.000338 |
0.002635 |
598 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
6 |
163 |
0.0003451 |
0.002685 |
599 |
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
4 |
59 |
0.0003579 |
0.002775 |
600 |
VASCULOGENESIS |
4 |
59 |
0.0003579 |
0.002775 |
601 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
7 |
232 |
0.0003711 |
0.002868 |
602 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
7 |
232 |
0.0003711 |
0.002868 |
603 |
LENS FIBER CELL DIFFERENTIATION |
3 |
25 |
0.0003786 |
0.002907 |
604 |
SPINDLE CHECKPOINT |
3 |
25 |
0.0003786 |
0.002907 |
605 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
3 |
25 |
0.0003786 |
0.002907 |
606 |
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
3 |
25 |
0.0003786 |
0.002907 |
607 |
NEGATIVE REGULATION OF CELL DIVISION |
4 |
60 |
0.0003818 |
0.002917 |
608 |
RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
7 |
233 |
0.0003808 |
0.002917 |
609 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
4 |
60 |
0.0003818 |
0.002917 |
610 |
CATABOLIC PROCESS |
22 |
1773 |
0.0003867 |
0.00295 |
611 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
12 |
662 |
0.0003975 |
0.003022 |
612 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
12 |
662 |
0.0003975 |
0.003022 |
613 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
5 |
109 |
0.0004017 |
0.003044 |
614 |
RESPONSE TO HYDROGEN PEROXIDE |
5 |
109 |
0.0004017 |
0.003044 |
615 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
4 |
61 |
0.0004068 |
0.003078 |
616 |
REGULATION OF HORMONE LEVELS |
10 |
478 |
0.0004102 |
0.003098 |
617 |
HEMOSTASIS |
8 |
311 |
0.000413 |
0.003114 |
618 |
SYSTEM PROCESS |
22 |
1785 |
0.0004243 |
0.003195 |
619 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
3 |
26 |
0.0004262 |
0.003198 |
620 |
REGULATION OF CELL FATE COMMITMENT |
3 |
26 |
0.0004262 |
0.003198 |
621 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
9 |
397 |
0.0004524 |
0.00339 |
622 |
STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
173 |
0.0004736 |
0.003543 |
623 |
SKELETAL MUSCLE TISSUE REGENERATION |
3 |
27 |
0.0004775 |
0.003549 |
624 |
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
3 |
27 |
0.0004775 |
0.003549 |
625 |
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION |
3 |
27 |
0.0004775 |
0.003549 |
626 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
3 |
27 |
0.0004775 |
0.003549 |
627 |
RESPONSE TO INTERLEUKIN 1 |
5 |
115 |
0.0005136 |
0.003805 |
628 |
RESPONSE TO CALCIUM ION |
5 |
115 |
0.0005136 |
0.003805 |
629 |
VENTRICULAR SEPTUM MORPHOGENESIS |
3 |
28 |
0.0005325 |
0.003908 |
630 |
GASTRULATION WITH MOUTH FORMING SECOND |
3 |
28 |
0.0005325 |
0.003908 |
631 |
PLACENTA BLOOD VESSEL DEVELOPMENT |
3 |
28 |
0.0005325 |
0.003908 |
632 |
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION |
3 |
28 |
0.0005325 |
0.003908 |
633 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
3 |
28 |
0.0005325 |
0.003908 |
634 |
MORPHOGENESIS OF A POLARIZED EPITHELIUM |
3 |
28 |
0.0005325 |
0.003908 |
635 |
RESPONSE TO STEROID HORMONE |
10 |
497 |
0.0005556 |
0.004065 |
636 |
MAMMARY GLAND DEVELOPMENT |
5 |
117 |
0.0005557 |
0.004065 |
637 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
12 |
689 |
0.0005671 |
0.004143 |
638 |
POSITIVE REGULATION OF NEURON DEATH |
4 |
67 |
0.000582 |
0.004244 |
639 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
3 |
29 |
0.0005915 |
0.004307 |
640 |
CELLULAR MACROMOLECULE LOCALIZATION |
17 |
1234 |
0.0006142 |
0.004465 |
641 |
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
4 |
68 |
0.0006157 |
0.004469 |
642 |
REGULATION OF SECRETION |
12 |
699 |
0.0006438 |
0.004666 |
643 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
5 |
121 |
0.0006475 |
0.004681 |
644 |
REGULATION OF SYSTEM PROCESS |
10 |
507 |
0.0006479 |
0.004681 |
645 |
POSITIVE REGULATION OF AXONOGENESIS |
4 |
69 |
0.0006507 |
0.004687 |
646 |
SYNAPSE ASSEMBLY |
4 |
69 |
0.0006507 |
0.004687 |
647 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR |
3 |
30 |
0.0006545 |
0.004693 |
648 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
3 |
30 |
0.0006545 |
0.004693 |
649 |
MYOTUBE CELL DEVELOPMENT |
3 |
30 |
0.0006545 |
0.004693 |
650 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
5 |
122 |
0.0006721 |
0.004811 |
651 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
4 |
70 |
0.0006871 |
0.004911 |
652 |
EPITHELIAL CELL DEVELOPMENT |
6 |
186 |
0.0006935 |
0.004949 |
653 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
5 |
123 |
0.0006975 |
0.00497 |
654 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
4 |
71 |
0.000725 |
0.005134 |
655 |
SKIN EPIDERMIS DEVELOPMENT |
4 |
71 |
0.000725 |
0.005134 |
656 |
SYNAPTIC SIGNALING |
9 |
424 |
0.0007244 |
0.005134 |
657 |
CELL FATE SPECIFICATION |
4 |
71 |
0.000725 |
0.005134 |
658 |
ENDOTHELIAL CELL DIFFERENTIATION |
4 |
72 |
0.0007643 |
0.005396 |
659 |
REGULATION OF HORMONE SECRETION |
7 |
262 |
0.0007642 |
0.005396 |
660 |
REGULATION OF ORGAN FORMATION |
3 |
32 |
0.000793 |
0.005574 |
661 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
3 |
32 |
0.000793 |
0.005574 |
662 |
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT |
3 |
32 |
0.000793 |
0.005574 |
663 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
4 |
73 |
0.0008051 |
0.005625 |
664 |
PANCREAS DEVELOPMENT |
4 |
73 |
0.0008051 |
0.005625 |
665 |
EMBRYONIC HEART TUBE DEVELOPMENT |
4 |
73 |
0.0008051 |
0.005625 |
666 |
G1 DNA DAMAGE CHECKPOINT |
4 |
73 |
0.0008051 |
0.005625 |
667 |
REGULATION OF DENDRITE MORPHOGENESIS |
4 |
74 |
0.0008474 |
0.005885 |
668 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
4 |
74 |
0.0008474 |
0.005885 |
669 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
74 |
0.0008474 |
0.005885 |
670 |
CELL CELL JUNCTION ASSEMBLY |
4 |
74 |
0.0008474 |
0.005885 |
671 |
REGULATION OF REPRODUCTIVE PROCESS |
5 |
129 |
0.0008648 |
0.005988 |
672 |
CELL JUNCTION ASSEMBLY |
5 |
129 |
0.0008648 |
0.005988 |
673 |
NEURAL CREST CELL DIFFERENTIATION |
4 |
75 |
0.0008912 |
0.006162 |
674 |
ORGAN FORMATION |
3 |
34 |
0.0009489 |
0.006541 |
675 |
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
3 |
34 |
0.0009489 |
0.006541 |
676 |
CELL PART MORPHOGENESIS |
11 |
633 |
0.0009867 |
0.006791 |
677 |
REGULATION OF GASTRULATION |
3 |
35 |
0.001034 |
0.007093 |
678 |
RESPONSE TO MINERALOCORTICOID |
3 |
35 |
0.001034 |
0.007093 |
679 |
ACTIN FILAMENT BASED PROCESS |
9 |
450 |
0.0011 |
0.00754 |
680 |
POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
3 |
36 |
0.001123 |
0.007672 |
681 |
HEAD MORPHOGENESIS |
3 |
36 |
0.001123 |
0.007672 |
682 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
7 |
280 |
0.001125 |
0.007676 |
683 |
HINDBRAIN DEVELOPMENT |
5 |
137 |
0.001132 |
0.007714 |
684 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
4 |
81 |
0.001188 |
0.008084 |
685 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
6 |
207 |
0.001207 |
0.008196 |
686 |
HINDLIMB MORPHOGENESIS |
3 |
37 |
0.001217 |
0.00823 |
687 |
MYOBLAST DIFFERENTIATION |
3 |
37 |
0.001217 |
0.00823 |
688 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
3 |
37 |
0.001217 |
0.00823 |
689 |
JNK CASCADE |
4 |
82 |
0.001244 |
0.0084 |
690 |
REGULATION OF SYNAPTIC PLASTICITY |
5 |
140 |
0.001247 |
0.008408 |
691 |
REGULATION OF CALCIUM ION TRANSPORT |
6 |
209 |
0.001268 |
0.008523 |
692 |
REGULATION OF PEPTIDE SECRETION |
6 |
209 |
0.001268 |
0.008523 |
693 |
HAIR CYCLE |
4 |
83 |
0.001301 |
0.008711 |
694 |
EMBRYONIC PLACENTA DEVELOPMENT |
4 |
83 |
0.001301 |
0.008711 |
695 |
MOLTING CYCLE |
4 |
83 |
0.001301 |
0.008711 |
696 |
REGULATION OF DEFENSE RESPONSE |
12 |
759 |
0.00131 |
0.008759 |
697 |
CELLULAR CATABOLIC PROCESS |
17 |
1322 |
0.001314 |
0.008769 |
698 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
3 |
38 |
0.001316 |
0.008771 |
699 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
4 |
84 |
0.00136 |
0.009042 |
700 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
4 |
84 |
0.00136 |
0.009042 |
701 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
9 |
465 |
0.001381 |
0.009166 |
702 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
6 |
213 |
0.001396 |
0.009255 |
703 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
5 |
144 |
0.001413 |
0.009351 |
704 |
POSITIVE REGULATION OF VIRAL TRANSCRIPTION |
3 |
39 |
0.001419 |
0.009354 |
705 |
NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
3 |
39 |
0.001419 |
0.009354 |
706 |
TRABECULA MORPHOGENESIS |
3 |
39 |
0.001419 |
0.009354 |
707 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
4 |
85 |
0.001421 |
0.009354 |
708 |
RESPONSE TO IONIZING RADIATION |
5 |
145 |
0.001457 |
0.009546 |
709 |
SYNAPSE ORGANIZATION |
5 |
145 |
0.001457 |
0.009546 |
710 |
NEGATIVE REGULATION OF MAPK CASCADE |
5 |
145 |
0.001457 |
0.009546 |
711 |
HOMEOSTATIC PROCESS |
17 |
1337 |
0.001483 |
0.009708 |
712 |
RESPONSE TO ESTRADIOL |
5 |
146 |
0.001502 |
0.009785 |
713 |
T CELL RECEPTOR SIGNALING PATHWAY |
5 |
146 |
0.001502 |
0.009785 |
714 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
6 |
216 |
0.001499 |
0.009785 |
715 |
APICAL JUNCTION ASSEMBLY |
3 |
40 |
0.001528 |
0.009918 |
716 |
REGULATION OF MEIOTIC CELL CYCLE |
3 |
40 |
0.001528 |
0.009918 |
717 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
3 |
40 |
0.001528 |
0.009918 |